疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

0 ]# G! ^1 }1 ]0 `/ Z6 ]: ZApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
8 P; B3 `- t9 ]" U4 p7 a
http://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
3 t$ J" D7 i8 r$ x8 P
4 P/ j* ^  _, E* USECTION 1: General aspects of vaccination
) N7 m/ q# e  N1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
( l  e3 L- y: Q  z  Ylicensed vaccines 71
) B# D$ ~) R+ S  o) q# ^7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
10 Anthrax vaccines 127
7 }5 i' M1 H$ }/ c: a1 D! y11 Cholera vaccines 141
12 Diphtheria toxoid 153
  T' O; q5 j, ]; O! G6 u13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
) q. m( O) ^2 f/ w5 o16 Human papillomavirus vaccines 235
1 T, r9 L* ^; h17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
: ^, r0 ]8 |0 N. F3 A( O5 V. f8 z% I20 Measles vaccines 352
% d: ]9 j. X: R3 O* N$ A21 Meningococcal vaccines 388
22 Mumps vaccine 419
; P0 G5 w# J& E- R) N, k0 r2 d23 Pertussis vaccines . 447
; c& |+ r. c1 E7 D. [- K24 Plague vaccines 493
: I3 ~" {0 t/ Q# ]25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
4 c( o: J# Z7 D1 z; P4 ^6 k26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
( a$ l% a1 @5 r. K. ?7 W5 y; R' X31 Rubella vaccine 688
5 F8 w: [" Q0 k' D+ s! @' F32 Smallpox and vaccinia 718
# i3 X- a- o3 }& u: R33 Tetanus toxoid 746
- ^: L& A7 S) r8 K; J! u, y34 Tick-borne encephalitis virus vaccines 773
4 o+ l, Z( W6 J7 S6 [& A: W) E$ `9 f35 Tuberculosis vaccines 789
5 J) v1 i  T; \, A( [36 Typhoid fever vaccines 812
37 Varicella vaccine 837
2 Z( ~; y% w' }+ s$ @0 t38 Yellow fever vaccine 870
/ X$ l, V8 [4 D+ O0 |39 Zoster vaccine 969
  y2 Q3 R$ |8 K7 J9 R! P40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
5 p& f2 f. D8 G8 V) ^8 s; A42 Therapeutic cancer vaccines 1018
0 B% W* {- U+ _- I6 v# z43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
  B) v) `+ X8 K/ B49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
' r2 B/ n/ @; J$ u* ~8 r51 Human immunodeficiency virus vaccines 1097
, f! a9 N% |, [) m5 w4 ~2 q! e52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
# q4 T8 P6 R9 S  N  z; |+ s+ q54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
9 z' P4 a$ b" Q4 {1 o; _: @58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
- h$ h+ y$ W0 R- o( l9 d1 }60 Technologies for making new vaccines 1182
. g; W9 w$ @9 b" S! ?0 R& K61 Alternative vaccine delivery methods 1200
& b% j0 u2 Q/ L2 I9 r' _+ i62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
* D0 |5 }( _, _& c63 Vaccination of immunocompromised hosts 1243
" j/ C, u4 J( h" a- d) q) \( J64 Vaccination of human immunodeficiency virus-infected persons 1257
  E1 h% Q+ E/ K) k* S3 \& j3 ]1 `65 Vaccines for international travel 1270
; Y9 D, n/ I1 b' G0 B66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
0 G' B2 b( K) u! _$ l68 Immunization in Europe . 1334
7 v: H( s+ b1 c& _8 n) @69 Immunization in the Asia-Pacific region 1353
$ z9 J1 p% ]8 A, v) L' Q70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
7 P! c, s# q- a$ l1 F  Z) p# F73 Regulation and testing of vaccines 1427
8 a( o1 \4 @( W* m3 _% V& Y. G74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
$ u* G1 l4 a7 d5 l4 \2 k76 Vaccine safety 1464
( O; U/ O8 R' F1 I$ n: V77 Legal issues . 1481
78 Ethics 1508
: n9 {4 N: p; p  N* d

1 J% v$ J2 c& a" H! y, V
, l" A5 ~) {1 ?7 U, V1 W9 }- ?! r, W

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

6 S' o" }9 `/ P; P, y: g* X- \Vaccines, 6th Edition
' u- Z6 n, T' r& e. [  w* D- s/ {
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

, o! L7 l. Q' M& U2 v/ Q# Thttp://yun.baidu.com/share/link? ... 1&uk=3810996606

# T8 M6 u; \9 A1 W0 W3 ~SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
  u! E7 Y: R4 u8 V& r( N' m' p4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
+ A7 s. c+ H4 Z6 Vaccine additives and manufacturing residuals in the United States:
4 `* C- Y* _. Z% K" Ylicensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
7 M, Y& F0 ?% I( @$ ]SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
% e  J/ W4 n- C- J) {10 Anthrax vaccines 127
, G3 {+ I+ T+ w$ i$ `" X4 z9 @& S& f11 Cholera vaccines 141
, z' n% \! a7 e4 W# m& n12 Diphtheria toxoid 153
8 N6 I- U. U) d4 d0 f+ }13 Haemophilus influenzae vaccines 167
0 c+ q' v8 b" O5 H0 z14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
. r2 e& A9 e% `" L; }( X16 Human papillomavirus vaccines 235
- J3 L: i- ~+ R1 m% e8 g17 Inactivated influenza vaccines 257
. ~: x2 k% ~2 r9 h8 L) H% M18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
" \! v( y6 b1 Y4 e% e) p* C5 @20 Measles vaccines 352
) {7 v2 x: Q7 X& B% W8 l21 Meningococcal vaccines 388
9 _3 P  U6 Z, m( K; x2 \7 [22 Mumps vaccine 419
2 N" A# H& @4 W8 X23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
$ l8 R9 K" n5 i, C4 X" v1 x1 G26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
/ X! P/ g- V+ |. q7 B; l28 Poliovirus vaccine-live 598
# \8 X* }9 F1 T29 Rabies vaccines .646
  z5 q4 g/ }2 @5 P% m. h- [" J! d30 Rotavirus vaccines . 669
3 g- r) ^+ h4 ^# a' g7 D31 Rubella vaccine 688
9 [' G. [% V, y- I# C32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
' G' q  @( q5 d+ N' n: d. _34 Tick-borne encephalitis virus vaccines 773
$ {/ U% O( S, Z35 Tuberculosis vaccines 789
- B+ N- p( m% e; u8 `9 |: B, l- \36 Typhoid fever vaccines 812
' `5 b% k# ~- F7 e37 Varicella vaccine 837
38 Yellow fever vaccine 870
2 T8 J) |0 h1 z/ s% K$ y39 Zoster vaccine 969
40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
- P/ C& [. Z$ r8 T+ a: P* B. Y0 f42 Therapeutic cancer vaccines 1018
/ c# r/ z0 p, O5 _6 s43 Cytomegalovirus vaccines 1032
1 l- H. X8 O+ V9 m3 h5 J; b7 ]- A44 Dengue vaccines 1042
/ X. ]- r: y" F) a9 T2 Q45 Diarrhea caused by bacteria 1052
# U6 F) s9 L2 n0 [( H. L46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
1 e7 F  K9 C! H/ ~+ G50 Herpes simplex virus vaccines 1090
3 h0 U6 D6 S, v: K% Y4 E8 R51 Human immunodeficiency virus vaccines 1097
4 |4 n) v( v3 J' ?! G' i52 Lyme disease vaccines 1122
: |* Z; `8 O4 P1 f, @2 @' W/ e  X& d( B53 Malaria vaccines 1133
" t0 x! O) \' t6 `4 L54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
. \6 k1 f+ n) P, E56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
9 o, y( b3 Z3 a" k58 Streptococcus group A vaccines 1169
# Z3 C# P& Q; ?. Q' ~% F, t59 Streptococcus group B vaccines 1176
  b7 [" L# h# Y, n, ^60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
. `/ L! N5 S) x% T* wSECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
& W: X( C  r. z3 y2 A# K6 {- S0 A64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
3 g8 M5 z% ]: V! b66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
, ^% }! v' ?0 I67 Immunization in the United States 1310
68 Immunization in Europe . 1334
/ f6 R$ N( q& H1 ?% W69 Immunization in the Asia-Pacific region 1353
1 V1 V# P5 G# g5 [; D70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
& D$ x( }4 H7 E4 }0 j+ B! n5 z73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
8 Y1 o8 t% R0 V. N$ g! }5 E76 Vaccine safety 1464
77 Legal issues . 1481
# H; S2 b7 J/ O6 w7 [78 Ethics 1508
% I6 f# R, S' W4 A4 a

8 K" O# y6 Q. L8 T! r' X5 U& ~

casarett

Vaccines, 6e, 2012

Hardcover: 1570 pages
# ~; _! U6 r8 _! zPublisher: Saunders; 6 edition (October 30, 2012)
Language: English
: p) l" {6 q. l$ ?* z, RISBN-10: 1455700908
Size: 52.3mb (original pdf)
6 N. S. @& p2 ~
, T: Z, R! h+ K- H0 g& Q' M2013 BMA Medical Book Awards Highly Commended in Public Health!
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

5 R( @, }& a8 K( iGain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
5 D' k$ o9 l* m! CGet complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
' n  E& O$ I0 x3 p% tAnalyze the cost-benefit and cost-effectiveness of different vaccine options.
. f9 E) N# e# j- O+ BClearly visualize concepts and objective data through an abundance of tables and figures.
Perform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
0 R2 c6 k$ s7 P; {' X: o+ F  a
Download link: http://pan.baidu.com/s/1i5NxwLR
& g$ h& x) N4 S& T  B. ?Code for downloading: dv96